diphenhydramine has been researched along with Alopecia in 7 studies
Diphenhydramine: A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.
diphenhydramine : An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug.
antitussive : An agent that suppresses cough. Antitussives have a central or a peripheral action on the cough reflex, or a combination of both. Compare with expectorants, which are considered to increase the volume of secretions in the respiratory tract, so facilitating their removal by ciliary action and coughing, and mucolytics, which decrease the viscosity of mucus, facilitating its removal by ciliary action and expectoration.
Alopecia: Absence of hair from areas where it is normally present.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study investigated the efficacy and safety of weekly administration of paclitaxel (PTX) for 37 patients with advanced or recurrent breast cancer." | 9.12 | [A phase II study of weekly paclitaxel for advanced or recurrent breast cancer]. ( Imai, S; Jitsuko, A; Nishikawa, H; Otoshi, M; Takahara, S; Tsubono, M; Wada, Y, 2007) |
| "Paclitaxel was administered by 1 h intravenous infusion at a dose of 80 mg/m2 every week." | 6.71 | Multicenter phase II trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01). ( Inoue, K; Kai, T; Koh, J; Mihara, H; Mochizuki, H; Okubo, K; Saito, T; Sato, K; Tabei, T, 2003) |
| "The present study investigated the efficacy and safety of weekly administration of paclitaxel (PTX) for 37 patients with advanced or recurrent breast cancer." | 5.12 | [A phase II study of weekly paclitaxel for advanced or recurrent breast cancer]. ( Imai, S; Jitsuko, A; Nishikawa, H; Otoshi, M; Takahara, S; Tsubono, M; Wada, Y, 2007) |
| "Paclitaxel was administered by 1 h intravenous infusion at a dose of 80 mg/m2 every week." | 2.71 | Multicenter phase II trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01). ( Inoue, K; Kai, T; Koh, J; Mihara, H; Mochizuki, H; Okubo, K; Saito, T; Sato, K; Tabei, T, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, K | 1 |
| Inoue, K | 1 |
| Saito, T | 1 |
| Kai, T | 1 |
| Mihara, H | 1 |
| Okubo, K | 1 |
| Koh, J | 1 |
| Mochizuki, H | 1 |
| Tabei, T | 1 |
| Terauchi, F | 1 |
| Nagashima, T | 1 |
| Kobayashi, Y | 1 |
| Yamamoto, Y | 1 |
| Moritake, T | 1 |
| Seiki, T | 1 |
| Ogura, H | 1 |
| Wada, Y | 1 |
| Otoshi, M | 1 |
| Jitsuko, A | 1 |
| Nishikawa, H | 1 |
| Takahara, S | 1 |
| Tsubono, M | 1 |
| Imai, S | 1 |
| Odom, LF | 1 |
| Gordon, EM | 1 |
| Edmonson, JH | 1 |
| Ebbert, LP | 1 |
| Nascimento, AG | 1 |
| Jung, SH | 1 |
| McGaw, H | 1 |
| Gerstner, JB | 1 |
| Uno, Y | 1 |
| Hirano, M | 1 |
| Murakami, N | 1 |
| Kikuchi, T | 1 |
| Nozawa, H | 1 |
| Okuda, T | 1 |
| Oya, J | 1 |
| Kikkawa, H | 1 |
| Wiernik, PH | 1 |
| Schwartz, EL | 1 |
| Strauman, JJ | 1 |
| Dutcher, JP | 1 |
| Lipton, RB | 1 |
| Paietta, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Adjuvant Dose-dense Sequential Chemotherapy With Epirubicin, CMF, and Weekly Docetaxel or Weekly Paclitaxel in Patients With Resected High-risk Breast Cancer: A Hellenic Cooperative Oncology Group (HeCOG) Study[NCT04829890] | 89 participants (Actual) | Observational | 2004-02-29 | Completed | |||
| Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer[NCT02549534] | 29 participants (Actual) | Observational | 2015-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for diphenhydramine and Alopecia
| Article | Year |
|---|---|
Multicenter phase II trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01).
Topics: Adult; Aged; Alopecia; Antiemetics; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Dexamethaso | 2003 |
[A phase II study of weekly paclitaxel for advanced or recurrent breast cancer].
Topics: Adult; Aged; Alopecia; Antiemetics; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neopla | 2007 |
Phase II study of docetaxel in advanced soft tissue sarcomas.
Topics: Adult; Aged; Alopecia; Anorexia; Antiemetics; Antineoplastic Agents, Phytogenic; Cause of Death; Dex | 1996 |
[Weekly administration of low-dose paclitaxel for advanced or metastatic breast cancer].
Topics: Aged; Alopecia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Dexamethasone; Diphenhydramine; | 2002 |
3 other studies available for diphenhydramine and Alopecia
| Article | Year |
|---|---|
A pilot study of weekly paclitaxel administration for patients with relapsed cervical cancer after heavy medication.
Topics: Agranulocytosis; Alopecia; Antiemetics; Antineoplastic Agents, Phytogenic; Cimetidine; Combined Moda | 2005 |
Acute monoblastic leukemia in infancy and early childhood: successful treatment with an epipodophyllotoxin.
Topics: Alopecia; Child; Child, Preschool; Diarrhea; Diphenhydramine; Drug Administration Schedule; Drug Hyp | 1984 |
Phase I clinical and pharmacokinetic study of taxol.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alkaloids; Alopecia; Cimetidine; Dexamethasone; Diph | 1987 |